Logos Global Management LP 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 7:29 pm Purchase | 2025-03-18 | 13D | Olema Pharmaceuticals, Inc. OLMA | Logos Global Management LP | 3,208,875 4.700% | 3,208,875 (New Position) | Filing |